'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

CompletedOBSERVATIONAL
Enrollment

661

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

July 11, 2025

Study Completion Date

July 11, 2025

Conditions
Ovarian CancerBreast CancerProstate CancerPancreatic Cancer
Trial Locations (18)

Unknown

Research Site, Ansan

Research Site, Bucheon-si

Research Site, Busan

Research Site, Changwon

Research Site, Daegu

Research Site, Daejeon

Research Site, Goyang

Research Site, Gunpo

Research Site, Hwaseong

Research Site, Ilsan

Research Site, Incheon

Research Site, Jeonju

Research Site, Seongnam

Research Site, Seoul

Research Site, Suwon

Research Site, Uijeongbu-si

Research Site, Yangsan

Research Site, Yŏngin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY